Trial Profile
A Phase 1 Study of 1-Methyl-D-tryptophan in Patients With Advanced Malignancies
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Indoximod (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 08 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 08 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 11 Jul 2013 New trial record